Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Irontaz
If you believe that they don't need to get a move on with CimetrA as a result of being able to sell the food supplement then that is fine.... each to their own...
" giving CimetrA a much longer product life than the length of this current pandemic."
haha ..it is a good job too...because by the time they get 252 patients and get the FDA approval and all that...they will be glad it can be of use beyond the pandemic !!!
meanwhile let's hope the food supplement helps significantly take the strain of all the financial outgoings ....
Not really Pokerchips. As Ron said in his report yesterday to quote as you always like to do....
You can also find the story of ArtemiC and CimetrA. We have developed, tested, and brought to market not one but two products that have the potential to significantly impact the daily horror we are going through globally with COVID. One, a food supplement that has been clinically proven to arrest the Cytokine Storm, which we took through Phase IIb trials, and the second, a phytomedicine poised to not only demonstrate significant results for COVID treatment but also for a host of other indications that carry the cytokine storm with them as a potential side effect – giving CimetrA a much longer product life than the length of this current pandemic.
"GSK and San Francisco-based Vir Biotechnology have struck an agreement with the European Commission to supply up to 220,000 doses of their therapy sotrovimab as a Covid-19 treatment. It’s a monoclonal antibody and will be used to treat adults and teenagers from the age of 12.
The contract has been signed by 16 of the 27 EU states.
The drug can be used to treat coronavirus patients with mild symptoms who don’t need oxygen."
"In June, the companies announced confirmatory full results for the Phase 3 COMET-ICE trial, which resulted in a 79% reduction (adjusted relative risk reduction) (p<0.001) in hospitalisations for more than 24 hours or death due to any cause by Day 29 compared to placebo, meeting the primary endpoint of the trial. "
https://www.gsk.com/en-gb/media/press-releases/gsk-and-vir-biotechnology-announce-joint-procurement-agreement-with-european-commission-for-covid-19-treatment-sotrovimab/
The competitors are already through phase III and making medical contracts ..MXC with CimetrATM better get a move on